Founded in September 2018, Beijing QL Biopharmaceutical (QL Biopharm) is a biopharmaceutical company specializing in the production of recombinant protein drugs using Escherichia coli. The company is dedicated to the development of innovative biological drugs aimed at treating chronic metabolic diseases, including diabetes, obesity, non-alcoholic steatohepatitis (NASH), and more, with the ultimate goal of improving people's qu...
Founded in September 2018, Beijing QL Biopharmaceutical (QL Biopharm) is a biopharmaceutical company specializing in the production of recombinant protein drugs using Escherichia coli. The company is dedicated to the development of innovative biological drugs aimed at treating chronic metabolic diseases, including diabetes, obesity, non-alcoholic steatohepatitis (NASH), and more, with the ultimate goal of improving people's quality of life. QL Biopharm has a robust research and development pipeline that includes 10 innovative recombinant protein drugs and biosimilars.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.